John Davis

Disclosure information not submitted.

Presentation(s):

• Session 1: Prostate Screening and Diagnosis

  Wednesday, July 16, 2025
  8:15 AM - 8:50 AM CEST

• Prostate cancer screening and diagnosis: Genetic tests applications in High-risk PCa (Decipher, 4k, PHI, GPS, urinary markers, exosomes, etc). Do we have benefits? When should I order?

  Wednesday, July 16, 2025
  8:15 AM - 8:25 AM CEST

• Prostate cancer screening and diagnosis: Q+A

  Wednesday, July 16, 2025
  8:45 AM - 8:50 AM CEST

• Recurrent Disease After Local Treatment: PSA persistence after surgery: when is the best time and optimal candidates to undergo Salvage RT

  Wednesday, July 16, 2025
  11:10 AM - 11:20 AM CEST

• Urologic Oncology Q + A

  Wednesday, July 16, 2025
  12:00 PM - 12:15 PM CEST

• Morning Moderators

  Wednesday, July 16, 2025
  8:15 PM - 8:40 AM CEST

• Live Case Kang Duo, Dual Operating Surgeons: Prof. Xuesong Li(IRCAD, France), Prof. Kunlin Yang,(Peking University First Hospital), Prof. Husan ( patient side surgeon) (Kazakhstan)

  Thursday, July 17, 2025
  10:30 AM - 11:30 AM CEST

• Welcome to Day 2 from Moderators, All Day Moderators

  Thursday, July 17, 2025
  1:30 PM CEST

• Session 1: Different Technical Approaches to RALP: Transvesical Single Port RALP

  Thursday, July 17, 2025
  2:30 PM - 2:45 PM CEST

• Session 2: Important Trends in Prostate Cancer

  Thursday, July 17, 2025
  2:55 PM - 3:40 PM CEST

• Session 3: Improving RALP Outcomes: NARUS Lecture: Surgical Management of High Risk Prostate Cancer and Oligometastatic disease: are we making a difference?

  Thursday, July 17, 2025
  4:30 PM - 4:40 PM CEST